Cencora is expanding its third-party logistics (3PL) capabilities across the US and Europe, bolstering its global network and specialized logistics services for pharmaceutical businesses worldwide.

In Europe, the pharmaceutical logistics solutions provider is expanding its footprint by integrating NextPharma Logistics in Germany, Austria, and Switzerland. Additionally, Cencora plans to open a new 3PL facility in Italy in 2026.

Cencora's specialized transport vehicle in the pharmaceutical logistics chain, meeting stringent storage requirements and international delivery standards. Photo: Cencora

In the US, Cencora will establish a 3PL facility spanning approximately 46,500 square meters in Texas by 2028. The company has also tripled its ultracold and deep-frozen storage capacity across its entire network.

"Pharmaceutical companies increasingly seek partners who can provide comprehensive support across multiple markets," stated Alina Chesnokova, Cencora's vice president of global 3PL commercialization. "With our expanded international 3PL services and commercialization solutions ecosystem, Cencora is uniquely positioned to meet this demand, helping businesses seamlessly expand into new markets and ensuring products are delivered on time and under the correct conditions."

Cencora is a global group that provides logistics solutions and services for the pharmaceutical and healthcare industries. It operates across various international markets, specializing in distribution, third-party logistics, cold chain management, and product commercialization support services.

By Nhu Y (Source: FleetOwner)